3
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Dysphagia Severity and Management in Patients with COVID-19

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          COVID-19 has resulted in unprecedented numbers of patients treated at intensive care units (ICUs). Dysphagia is a key concern in critical illness survivors. We investigated the severity of dysphagia in COVID-19 and the need to adapt practices to provide efficient care. We reviewed the literature on COVID-19, post-critical-illness dysphagia, and dysphagia and tracheostomy guidelines during the pandemic. Critically ill COVID-19 patients present a high incidence of dysphagia, aggravated by respiratory distress, deconditioning, and neurological complications. Mechanical ventilation (MV), delirium, sedation and weakness are worse in COVID-19 than in other etiologies of critical care. In awake patients, respiratory compromise impairs breathing-swallowing-coughing coordination. Tracheostomy reduces laryngopharyngeal trauma, sedation, delirium, ICU stay and improves swallowing rehabilitation. Tracheostomy weaning and swallowing evaluation is complex in COVID-19 due to respiratory instability and a team discussion will guide adaptations. Patients assessed in the ICU were 67% recommended to be nil by mouth (were aspirating). Two months following hospital discharge, 83% of those who had undergone tracheostomy were managing a normal diet. Severely ill COVID-19 patients are expected to regain swallow function. Dysphagia care is based on adaptation of practices to the patients’ multiple impairments.

          Related collections

          Most cited references46

          • Record: found
          • Abstract: found
          • Article: not found

          Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China

          The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, is serious and has the potential to become an epidemic worldwide. Several studies have described typical clinical manifestations including fever, cough, diarrhea, and fatigue. However, to our knowledge, it has not been reported that patients with COVID-19 had any neurologic manifestations.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings

            Abstract Preliminary clinical data indicate that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with neurological and neuropsychiatric illness. Responding to this, a weekly virtual coronavirus disease 19 (COVID-19) neurology multi-disciplinary meeting was established at the National Hospital, Queen Square, in early March 2020 in order to discuss and begin to understand neurological presentations in patients with suspected COVID-19-related neurological disorders. Detailed clinical and paraclinical data were collected from cases where the diagnosis of COVID-19 was confirmed through RNA PCR, or where the diagnosis was probable/possible according to World Health Organization criteria. Of 43 patients, 29 were SARS-CoV-2 PCR positive and definite, eight probable and six possible. Five major categories emerged: (i) encephalopathies (n = 10) with delirium/psychosis and no distinct MRI or CSF abnormalities, and with 9/10 making a full or partial recovery with supportive care only; (ii) inflammatory CNS syndromes (n = 12) including encephalitis (n = 2, para- or post-infectious), acute disseminated encephalomyelitis (n = 9), with haemorrhage in five, necrosis in one, and myelitis in two, and isolated myelitis (n = 1). Of these, 10 were treated with corticosteroids, and three of these patients also received intravenous immunoglobulin; one made a full recovery, 10 of 12 made a partial recovery, and one patient died; (iii) ischaemic strokes (n = 8) associated with a pro-thrombotic state (four with pulmonary thromboembolism), one of whom died; (iv) peripheral neurological disorders (n = 8), seven with Guillain-Barré syndrome, one with brachial plexopathy, six of eight making a partial and ongoing recovery; and (v) five patients with miscellaneous central disorders who did not fit these categories. SARS-CoV-2 infection is associated with a wide spectrum of neurological syndromes affecting the whole neuraxis, including the cerebral vasculature and, in some cases, responding to immunotherapies. The high incidence of acute disseminated encephalomyelitis, particularly with haemorrhagic change, is striking. This complication was not related to the severity of the respiratory COVID-19 disease. Early recognition, investigation and management of COVID-19-related neurological disease is challenging. Further clinical, neuroradiological, biomarker and neuropathological studies are essential to determine the underlying pathobiological mechanisms, which will guide treatment. Longitudinal follow-up studies will be necessary to ascertain the long-term neurological and neuropsychological consequences of this pandemic.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Covid-19 and Post Intensive Care Syndrome: A Call for Action

                Bookmark

                Author and article information

                Journal
                Curr Health Sci J
                Curr Health Sci J
                CHSJ
                Current Health Sciences Journal
                Medical University Publishing House Craiova
                2067-0656
                2069-4032
                Apr-Jun 2021
                30 June 2021
                : 47
                : 2
                : 147-156
                Affiliations
                [1 ] 1stOtorhinolaryngology Department, School of Medicine, Faculty of Health Sciences,Aristotle University of Thessaloniki, Greece
                [2 ]Department of ENT and HNS, Faculty of Medicine, Comenius University, University Hospital Bratislava, Slovakia
                [3 ]Institute of Cancer and Genomic Sciences, University of Birmingham, UK
                [4 ]Department of Communication Disorders, Faculty of Education, Comenius University, Bratislava, Slovakia
                [5 ] 3rdSurgery Department, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, Greece
                Author notes
                Corresponding Author: Athanasia Printza 1st Otorhinolaryngology DepartmentSchool of Medicine Faculty of Health Sciences Aristotle University of Thessaloniki 54124, ThessalonikiGreece aprintza@ 123456auth.gr
                Article
                2021.2.01
                10.12865/CHSJ.47.02.01
                8551886
                34765231
                7475fa6c-f607-49bf-8853-7e5d97f86315
                Copyright © 2014, Medical University Publishing House Craiova

                This is an open-access article distributed under the terms of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License, which permits unrestricted use, adaptation, distribution and reproduction in any medium, non-commercially, provided the new creations are licensed under identical terms as the original work and the original work is properly cited.

                History
                : 05 April 2021
                : 07 June 2021
                Categories
                Review

                dysphagia,covid-19,swallowing,critically ill,tracheostomy
                dysphagia, covid-19, swallowing, critically ill, tracheostomy

                Comments

                Comment on this article